103 related articles for article (PubMed ID: 16343285)
1. Inhibitory effects of the beta-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-alpha in vitro and in vivo.
Verhoeckx KC; Doornbos RP; van der Greef J; Witkamp RF; Rodenburg RJ
J Vet Pharmacol Ther; 2005 Dec; 28(6):531-7. PubMed ID: 16343285
[TBL] [Abstract][Full Text] [Related]
2. In search of secreted protein biomarkers for the anti-inflammatory effect of beta2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis tools.
Verhoeckx KC; Gaspari M; Bijlsma S; van der Greef J; Witkamp RF; Doornbos RP; Rodenburg RJ
J Proteome Res; 2005; 4(6):2015-23. PubMed ID: 16335946
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic receptor blockade attenuates the exercise-induced suppression of TNF-alpha in response to lipopolysaccharide in rats.
Kitamura H; Shiva D; Woods JA; Yano H
Neuroimmunomodulation; 2007; 14(2):91-6. PubMed ID: 17713356
[TBL] [Abstract][Full Text] [Related]
5. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes.
Mizuno K; Takahashi HK; Iwagaki H; Katsuno G; Kamurul HA; Ohtani S; Mori S; Yoshino T; Nishibori M; Tanaka N
Immunol Lett; 2005 Nov; 101(2):168-72. PubMed ID: 15998544
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.
Severn A; Rapson NT; Hunter CA; Liew FY
J Immunol; 1992 Jun; 148(11):3441-5. PubMed ID: 1350291
[TBL] [Abstract][Full Text] [Related]
8. Dopamine inhibits responses of astroglia-enriched cultures to lipopolysaccharide via a beta-adrenoreceptor-mediated mechanism.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Arcidiacono D; Leon A
J Neuroimmunol; 2004 May; 150(1-2):29-36. PubMed ID: 15081246
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation.
Izeboud CA; Hoebe KH; Grootendorst AF; Nijmeijer SM; van Miert AS; Witkamp RR; Rodenburg RJ
Inflamm Res; 2004 Mar; 53(3):93-9. PubMed ID: 15021963
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.
Kern C; Meyer T; Droux S; Schollmeyer D; Miculka C
J Med Chem; 2009 Mar; 52(6):1773-7. PubMed ID: 19245211
[TBL] [Abstract][Full Text] [Related]
11. Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.
Jalonen U; Paukkeri EL; Moilanen E
J Pharmacol Exp Ther; 2008 Aug; 326(2):514-22. PubMed ID: 18469159
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages.
Verhoeckx KC; Doornbos RP; Witkamp RF; van der Greef J; Rodenburg RJ
Int Immunopharmacol; 2006 Jan; 6(1):1-7. PubMed ID: 16332507
[TBL] [Abstract][Full Text] [Related]
14. Zilpaterol hydrochloride alters abundance of β-adrenergic receptors in bovine muscle cells but has little effect on de novo fatty acid biosynthesis in bovine subcutaneous adipose tissue explants.
Miller EK; Chung KY; Hutcheson JP; Yates DA; Smith SB; Johnson BJ
J Anim Sci; 2012 Apr; 90(4):1317-27. PubMed ID: 22079997
[TBL] [Abstract][Full Text] [Related]
15. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
Piao N; Ikejima K; Kon K; Aoyama T; Osada T; Takei Y; Sato N; Watanabe S
Life Sci; 2009 Oct; 85(17-18):617-24. PubMed ID: 19647752
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease.
Gobejishvili L; Barve S; Joshi-Barve S; Uriarte S; Song Z; McClain C
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G681-8. PubMed ID: 16751174
[TBL] [Abstract][Full Text] [Related]
17. Bimodal effect of humic acids on the LPS-induced TNF-alpha release from differentiated U937 cells.
Junek R; Morrow R; Schoenherr JI; Schubert R; Kallmeyer R; Phull S; Klöcking R
Phytomedicine; 2009 May; 16(5):470-6. PubMed ID: 19131228
[TBL] [Abstract][Full Text] [Related]
18. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
Murai M; Tsuji F; Nose M; Seki I; Oki K; Setoguchi C; Suhara H; Sasano M; Aono H
Eur J Pharmacol; 2008 Jul; 588(2-3):309-15. PubMed ID: 18508045
[TBL] [Abstract][Full Text] [Related]
19. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice.
Brustolim D; Ribeiro-dos-Santos R; Kast RE; Altschuler EL; Soares MB
Int Immunopharmacol; 2006 Jun; 6(6):903-7. PubMed ID: 16644475
[TBL] [Abstract][Full Text] [Related]
20. The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes.
Yan M; Xia C; Cheng C; Shao X; Niu S; Liu H; Shen A
Brain Res; 2007 Dec; 1184():28-37. PubMed ID: 17980351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
